ITI News Archive
Stanford Medicine News
50th-anniversary celebration of heart transplant
The landmark heart transplant performed at Stanford in 1968 ultimately led to the success of the operation around the world today.
Landmark heart surgery changed history
On Jan. 6, 1968, as Stanford surgeon Norman Shumway performed the first U.S. adult heart transplantation, the world held its breath.
Screen could reveal immunotherapy targets
Stanford scientists have developed a biochemical screen that identifies molecules critical to immunotherapy for a host of diseases, including cancer.
Drug blocks several mosquito-borne viruses
A new Stanford study details how to shut off proteins in mammalian cells to keep viruses such as Zika, dengue and West Nile from replicating in them.
Multiple food allergies treated safely
Combining an antibody drug, omalizumab, with a procedure to desensitize children to multiple food allergies is safe and effective, according to a new study by Stanford researchers.
Second ‘don’t eat me’ signal found on cancer
CD47 is an important inhibitor of cancer-killing immune cells called macrophages. Now Stanford researchers have identified another, similar way to activate macrophages to destroy cancer cells.
‘Drugs’ from gut bugs
Stanford researchers found that manipulating the gut microbe Clostridium sporogenes changed levels of molecules in the bloodstreams of mice and, in turn, affected their health.
Possible new cell therapy for leukemia
Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.
Previously uncharacterized bacteria found in dolphins
Researchers have discovered poorly understood bacterial lineages in the mouths of dolphins.
Center to support cancer immunotherapy
Stanford is one of four institutions to receive National Cancer Institute funding to analyze patients’ immune function and tumor profiles as part of a public-private partnership to accelerate cancer therapies.